Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




PWRM, NGSX, DrStockPick.com Stock Report! Power 3 Medical Products Inc. and NeurogesX, Inc.

Dr. Stock Pick (November 17th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Tuesday November 17, 2009

DrStockPick.com Stock Report!

PWRM, NGSX

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. PWRM’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). PWRM expects to complete phase II clinical validation trials of

...
Tags for this Post:
1-201-689-8562, 1-877-407-0789, advertisement services, ALS, Beijing, Biopharmaceutical, Breast Cancer, broker, cancer, Chair and Keynote Speaker, chief scientific officer, China, Congress, corporate Web site, Crown Equity Holdings Inc.;, diagnostic tests, Dr Stock Pick, equity trader, Fda, Garmin GDL 30A GPS Receiver, Houston, International Congress, Investing Lessons, Ira Goldknopf, Live Web, nerve pain, neurodegenerative disease;, NeurogesX Inc, NGSX, pain, pain management, postherpetic neuralgia;, Power 3 Medical Products Inc., president, professional investment analyst and consultant, PWRM, Qutenza(TM) (capsaicin), Qutenza(TM);, Qutenza;, shingles, stock featured on our site;, Stock Pick, Stocks to Watch, Texas, U.S. Food and Drug Administration, United States, USD, www.BestOTC.com, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.neurogesx.com, www.PennyOmega.com, www.power3medical.com, www.stock-ir.com, www.stock-pr.com

NGSX, GRMN, VGPR, DrStockPick.com Watch List! for Tuesday Nov 17, 2009, NeurogesX, Inc., Garmin Ltd. and Vega Promotional Systems Inc., VGPR.PK

Dr. Stock Pick (November 16th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

DrStockPick.com Watch List!

My Picks for Tuesday November 17, 2009 are:

**************************************************************

NGSX, NeurogesX, Inc.

NGSX is a biopharmaceutical company focused on developing and commercializing novel pain management therapies.

** The U.S. Food and Drug Administration (FDA) has approved NGSX’s Qutenza(TM) (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia, the nerve pain which can follow an attack of shingles.

NGSX’s Qutenza delivers a synthetic form of capsaicin, the substance in chili peppers that gives them their heat sensation, through a dermal delivery system, providing up to 12 weeks of reduced

...
Tags for this Post:
AIS;, Automatic Identification System, bio-diesel products, biofuel products, Biopharmaceutical, broker, Crown Equity Holdings Inc.;, Dr Stock Pick, Electricity, energy efficient pellet fuel, equity trader, Garmin International Inc., Garmin Ltd, gas lines, Green Valley, Green Valley coal mine, grmn, Investing Lessons, methane gas, multifaceted green energy power production facility, nerve pain, NeurogesX Inc, NGSX, organic waste bi-products, pain, pain management, postherpetic neuralgia;, professional investment analyst and consultant, Qutenza(TM) (capsaicin), satellite navigation;, shingles, stock featured on our site;, Stock Pick, Stocks to Watch, Tennessee Power Company, thermal energy;, U.S. Food and Drug Administration, Vega Promotional Systems Inc., VGPR, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.garmin.com, www.neurogesx.com, www.stock-ir.com

DrStockPick.com Stock Report! 7/24/09, DPTR, NGSX, POWR, AVD, CYTX, JAGH

Dr. Stock Pick (July 24th, 2009) Writes:

DrStockPick.com Stock Report!

Friday July 24, 2009

**************************************************************

Delta Petroleum Corporation (Nasdaq: DPTR); an independent oil and gas exploration and development company, today announced that it will host an investor conference call on Thursday, August 6, 2009 at 12:00 noon Eastern Time (10:00 am Mountain Time) to discuss operating results for the second quarter 2009.

NeurogesX, Inc. (Nasdaq: NGSX) announced today the preliminary results of a short-term clinical study (Study C123) of Qutenza(TM) in patients with postherpetic neuralgia (PHN) following pretreatment with an FDA-approved topical anesthetic. As part of the ongoing new drug application (NDA) review, the U.S. Food and Drug Administration (FDA) requested the study to determine whether an FDA-approved topical anesthetic would provide similar tolerability to the topical agent used as a pretreatment

...

Zacks Analyst Blog Highlights: Lloyds Banking Group plc, CBS Corporation, Somaxon Pharmaceuticals, Alexza Pharmaceuticals and NeurogesX, Inc. – Press Releases

Zacks Market Commentaries (May 11th, 2009) Writes:
For Immediate Release

Chicago, IL - May 11, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Lloyds Banking Group plc (LYG), CBS Corporation (CBS), Somaxon Pharmaceuticals (SOMX), Alexza Pharmaceuticals (ALXA) and NeurogesX, Inc. (NGSX).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Friday's Analyst Blog:

Lloyds Still Expects a Loss

Today in its first quarter trading update, Lloyds Banking Group plc (LYG, or Lloyds) announced that it still expects to post a loss for full-year 2009 (excluding an accounting gain from negative goodwill) on the back of

...

NeurogesX Fundamentals Improve – Analyst Blog

Zacks Market Commentaries (March 23rd, 2009) Writes:
NeurogesX Fundamentals Dramatically ImprovingNeurogesX, Inc.'s (NGSX) Qutenza, a cutaneous (skin) patch designed to treat peripheral neuropathic pain conditions, has significant market opportunity, in our view. The neuropathic pain market is multi-billion dollar, and the clinical data, at least in post-hepatic neuralgia (PHN), looks very good.We are very pleased to see the positive opinion issued by the EMEA-CHMP in March 2009. We note that treatment of neuropathic pain often involves multiple products, and that the Qutenza profile of infrequent dosing with no systemic side-effects or drug-drug interactions will fit very well into the poly-pharmacy model.In this regard, we are very pleased that the proposed EU label allows for the use of poly-pharmacy. Odds now clearly favor approval in the EU in the next 60 to 90 days. According to management, they are in "very late stage" discussions with potential pan-European partners, and a ...

NeurogesX Fundamentals Improve – Analyst Blog

Zacks Market Commentaries (March 23rd, 2009) Writes:
NeurogesX Fundamentals Dramatically ImprovingNeurogesX, Inc.'s (NGSX) Qutenza, a cutaneous (skin) patch designed to treat peripheral neuropathic pain conditions, has significant market opportunity, in our view. The neuropathic pain market is multi-billion dollar, and the clinical data, at least in post-hepatic neuralgia (PHN), looks very good.We are very pleased to see the positive opinion issued by the EMEA-CHMP in March 2009. We note that treatment of neuropathic pain often involves multiple products, and that the Qutenza profile of infrequent dosing with no systemic side-effects or drug-drug interactions will fit very well into the poly-pharmacy model.In this regard, we are very pleased that the proposed EU label allows for the use of poly-pharmacy. Odds now clearly favor approval in the EU in the next 60 to 90 days. According to management, they are in "very late stage" discussions with potential pan-European partners, and a ...

Zacks #1 Rank Additions for Friday – Zacks Tale of the Tape

Zacks Market Commentaries (October 3rd, 2008) Writes:

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

AZZ Inc (AZZ) Celadon Group Inc (CLDN) China BAK Battery Inc (CBAK) Citi Trends Inc (CTRN) Cleco Corp (CNL) CMS Energy Corp (CMS) CTS Corp (CTS) Curtiss-Wright Corp (CW) The Walt Disney Co (DIS) Flowserve Corp (FLS) FX Energy Inc (FXEN) GulfMark Offshore Inc (GLF) Huntington Bancshares Inc (HBAN) Interleukin Genetics Inc (ILI) Kirkland's Inc (KIRK) The Laclede Group Inc (LG) NeurogesX Inc (NGSX) Nicor Inc (GAS) Powerwave Technologies Inc (PWAV) Progress Energy Inc (PGN) SeaChange International (SEAC) Shenandoah Telecommunications Co (SHEN) ShengdaTech Inc (SDTH) TravelCenters of America LLC (TA) Universal Stainless & Alloy Products (USAP) View the entire Zacks #1 Rank List.

"AZZ" ...

Zacks #1 Rank Additions for Wednesday – Zacks Tale of the Tape

Zacks Market Commentaries (October 1st, 2008) Writes:

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Allegiant Travel Co (ALGT) Applied Energetics Inc (AERG) Astoria Financial Corp (AF) Aviza Technology Inc (AVZA) AZZ Inc (AZZ) BigBand Networks Inc (BBND) Boardwalk Pipeline Partners LP (BWP) BreitBurn Energy Partners LP (BBEP) Bruker Corp (BRKR) Carter's Inc (CRI) Casey's General Stores Inc (CASY) Cell Genesys Inc (CEGE) Cleco Corp (CNL) Colonial Properties Trust (CLP) CryoLife Inc (CRY) dELiA*s Inc (DLIA) The Empire District Electric Co (EDE) Fairfax Financial Holdings Ltd (FFH) Federal Signal Corp (FSS) Fossil Inc (FOSL) FX Energy Inc (FXEN) Hollywood Media Corp (HOLL) iCAD INC (ICAD) Iconix Brand Group Inc (ICON) Masimo Corp (MASI) NeurogesX Inc (NGSX) NitroMed Inc (NTMD) Occam Networks Inc (...
Tags for this Post:
Allegiant Travel Co, America, Applied Energetics Inc, Astoria Financial Corp, Aviza Technology Inc, Azz Inc, BigBand Networks Inc, Boardwalk Pipeline Partners LP, BreitBurn Energy Partners LP, Bruker Corp, Carter's Inc, Casey's General Stores Inc, Cell Genesys Inc., Cleco Corp., Colonial Properties Trust, Cryolife Inc, Fairfax Financial Holdings Ltd, Federal Signal Corp, Fossil Inc, FX Energy Inc, Hollywood Media Corp., iCAD INC, Iconix Brand Group Inc, Masimo Corp, NeurogesX Inc, NitroMed Inc, Occam Networks Inc, Parker Drilling Co, PMC-Sierra Inc, Potash Corp., Quality Distribution Inc, Reed's Inc., Regeneron Pharmaceuticals Inc, Ryder System Inc, Sally Beauty Holdings Inc, Saskatchewan, Schering-Plough Corp., Shoe Carnival Inc, Sport Supply Group Inc, Stocks to Watch, TAM SA, Targacept Inc, Tata Motors Ltd., The Empire District Electric Co, Trubion Pharmaceuticals Inc, Tyco International Ltd, Varian Medical Systems Inc, Xinhua Finance Media Ltd, Zhongpin Inc.

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.